The group’s principle activity is to provide innovative, pioneering technology that helps biotech and pharmaceutical companies examine drug candidates and bring new medicines to market more quickly. The group’s products include AVANTRA(TM)Q400 Biomarker Workstation, iMARK BIOCHIP(TM), MAX BIOCHIP(TM) and Path(R) Substrates. The group operates from United States.
